GGrantIndex
← Search

THE HEPATITIS C ANTIVIRAL LONG-TERM TREATMENT AGAINST CIRRHOSIS (HALT-C) TRIAL

$86,543M01FY2005RRNIH

Massachusetts General Hospital, Boston MA

Investigators

Linked publications, trials & patents

View original record on NIH RePORTER →
THE HEPATITIS C ANTIVIRAL LONG-TERM TREATMENT AGAINST CIRRHOSIS (HALT-C) TRIAL · GrantIndex